These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 3047366)
1. Cardiovascular actions of the primate-selective renin inhibitor, A-62198. Kleinert HD; Martin D; Chekal M; Young G; Rosenberg S; Plattner JJ; Perun TJ J Pharmacol Exp Ther; 1988 Sep; 246(3):975-9. PubMed ID: 3047366 [TBL] [Abstract][Full Text] [Related]
2. Effects of the renin inhibitor A-64662 in monkeys and rats with varying baseline plasma renin activity. Kleinert HD; Martin D; Chekal MA; Kadam J; Luly JR; Plattner JJ; Perun TJ; Luther RR Hypertension; 1988 Jun; 11(6 Pt 2):613-9. PubMed ID: 3292414 [TBL] [Abstract][Full Text] [Related]
3. Renal hemodynamic and excretory responses to renin inhibition induced by A-64662. Verburg KM; Kleinert HD; Chekal MA; Kadam JR; Young GA J Pharmacol Exp Ther; 1990 Feb; 252(2):449-55. PubMed ID: 2179529 [TBL] [Abstract][Full Text] [Related]
4. Effect of an orally active renin inhibitor Cl-992 on blood pressure in normotensive and hypertensive monkeys. Ryan MJ; Hicks GW; Batley BL; Rapundalo ST; Patt WC; Taylor DG; Keiser JA J Pharmacol Exp Ther; 1994 Jan; 268(1):372-9. PubMed ID: 8301578 [TBL] [Abstract][Full Text] [Related]
5. Acute effects of a pseudo-tetrapeptide as renin inhibitor on blood pressure and renin-angiotensin system of sodium-repleted and sodium-depleted hypertensive patients. Denolle T; Luo P; Guyene TT; Cazaubon C; Sissmann J; Corvol P; Ménard J Arzneimittelforschung; 1993 Feb; 43(2A):255-9. PubMed ID: 8498973 [TBL] [Abstract][Full Text] [Related]
6. [The captopril test--an aid in the detection of scarring nephropathy as a cause of arterial hypertension in children]. Peco-Antić A; Nastić-Mirić D; Babić D; Kostić M Srp Arh Celok Lek; 1999; 127(9-10):305-11. PubMed ID: 10649899 [TBL] [Abstract][Full Text] [Related]
7. Acute hypotensive responses to peptide inhibitors of renin in conscious monkeys: an effect on blood pressure independent of plasma renin inhibition. Schaffer LW; Schorn TW; Winquist RJ; Strouse JF; Payne L; Chakravarty PK; de Laszlo SE; tenBroeke J; Veber DF; Greenlee WJ J Hypertens; 1990 Mar; 8(3):251-9. PubMed ID: 2159506 [TBL] [Abstract][Full Text] [Related]
9. An orally active renin inhibitor: cyclohexylnorstatine-containing dipeptide (KRI-1314). Miyazaki M; Etoh Y; Iizuka K; Toda N J Hypertens Suppl; 1989 Apr; 7(2):S25-7. PubMed ID: 2666609 [TBL] [Abstract][Full Text] [Related]
10. Synergistic effect on reduction in blood pressure with coadministration of the renin inhibitor, CP-80,794, and the angiotensin converting enzyme inhibitor, captopril. Fossa AA; Weinberg LJ; Barber RL; Rauch AL; Nocerini MR; Murphy WR; Swindell AC J Cardiovasc Pharmacol; 1992 Jul; 20(1):75-82. PubMed ID: 1383634 [TBL] [Abstract][Full Text] [Related]
11. Antihypertensive properties of a new long-acting angiotensin converting enzyme inhibitor in renin-dependent and independent hypertensive models. Nagata S; Takeyama K; Fukuya F; Nagai R; Hosoki K; Nishimura K; Deguchi T; Karasawa T Arzneimittelforschung; 1995 Aug; 45(8):853-8. PubMed ID: 7575746 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of a potent inhibitor of subprimate and primate renins. Wood JM; Mah SC; Baum HP; de Gasparo M; Cumin F; Rüeger H; Nussberger J J Pharmacol Exp Ther; 1990 May; 253(2):513-7. PubMed ID: 2110974 [TBL] [Abstract][Full Text] [Related]
13. Activation of serotonin2 (5-HT2) receptors by quipazine increases arterial pressure and renin secretion in conscious rats. Alper RH; Snider JM J Pharmacol Exp Ther; 1987 Dec; 243(3):829-33. PubMed ID: 3320345 [TBL] [Abstract][Full Text] [Related]
14. Cardiovascular effects of centrally administered arachidonic acid in haemorrhage-induced hypotensive rats: investigation of a peripheral mechanism. Yalcin M; Aydin C Clin Exp Pharmacol Physiol; 2009 Apr; 36(4):447-53. PubMed ID: 19702598 [TBL] [Abstract][Full Text] [Related]
15. [Hypotensive effect of a human anti-renin monoclonal antibody (4G1D8) in the sodium-depleted alert marmoset]. Cazaubon C; Carlet C; Richaud JP; Nisato D; Corvol P; Gagnol JP Arch Mal Coeur Vaiss; 1986 Jun; 79(6):840-6. PubMed ID: 3099700 [TBL] [Abstract][Full Text] [Related]
16. Antihypertensive activity of captopril (SQ 14,225), an orally active inhibitor of angiotensin converting enzyme in conscious two-kidney perinephritic hypertensive dogs. Vollmer RR; Boccagno JA; Steinbacher TE; Horovitz ZP; Murthy VS J Pharmacol Exp Ther; 1981 Feb; 216(2):225-31. PubMed ID: 6257882 [TBL] [Abstract][Full Text] [Related]
17. Humoral effects of selective adenosine agonists in spontaneously hypertensive rats. Sala C; Monopoli A; Alberti C; Casati C; Ongini E; Zanchetti A; Morganti A J Hypertens; 1996 Jan; 14(1):75-9. PubMed ID: 12013498 [TBL] [Abstract][Full Text] [Related]
18. Hypotensive effects of the renin inhibitor (RI-78) and the converting enzyme inhibitor (teprotide) in conscious monkeys. Takaori K; Hartley LH; Burton J Clin Exp Hypertens A; 1987; 9(2-3):387-90. PubMed ID: 3038400 [TBL] [Abstract][Full Text] [Related]
19. Effects of renin inhibition in the conscious primate Macaca fascicularis. Hui KY; Knight DR; Nussberger J; Hartley LH; Vatner SF; Haber E Hypertension; 1989 Nov; 14(5):480-7. PubMed ID: 2680962 [TBL] [Abstract][Full Text] [Related]
20. Effects of a renin inhibitor, SR 43845, and of captopril on blood pressure and plasma active renin in conscious sodium-replete macaca. Lacour C; Cazaubon C; Roccon A; Segondy D; Wagnon J; Nisato D J Hypertens Suppl; 1989 Apr; 7(2):S33-5. PubMed ID: 2666612 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]